지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2019.1
- 수록면
- 155 - 161 (7page)
이용수
초록· 키워드
오류제보하기
Following the first successful trial of surfactant replacement therapy for preterm infants with respiratory distress syndrome (RDS) by Fujiwara in 1980, several animal-derived natural surfactants and synthetic surfactants have been developed. Synthetic surfactants were designed to overcome limitations of natural surfactants such as cost, immune reactions, and infections elicited by animal proteins contained in natural surfactants. However, first-generation synthetic surfactants that are protein-free have failed to prove their superiority over natural surfactants because they lack surfactant protein (SP). Lucinactant, a second-generation synthetic surfactant containing the SP-B analog, was better or at least as effective as the natural surfactant, suggesting that lucinactant could act an alternative to natural surfactants. Lucinactant was approved by the U. S. Food and Drug Administration in March 2012 as the fifth surfactant to treat neonatal RDS. CHF5633, a second-generation synthetic surfactant containing SP-B and SP-C analogs, was effective and safe in a human multicenter cohort study for preterm infants. Many comparative studies of natural surfactants used worldwide have reported different efficacies for different preparations. However, these differences are believed to due to site variations, not actual differences. The more important thing than the composition of the surfactant in improving outcome is the timing and mode of administration of the surfactant. Novel synthetic surfactants containing synthetic phospholipid incorporated with SP-B and SP-C analogs will potentially represent alternatives to natural surfactants in the future, while improvement of treatment modalities with less-invasive or noninvasive methods of surfactant administration will be the most important task to be resolved.
목차
등록된 정보가 없습니다.
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
신생아 호흡곤란증후군에서 인공 폐표면활성제의 사용
대한의사협회지
2015 .01
-
Efficacy of Surfactant-TA, Calfactant and Poractant Alfa for Preterm Infants with Respiratory Distress Syndrome: A Retrospective Study
Yonsei Medical Journal
2015 .01
-
Development of a Synthetic Surfactant Using a Surfactant Protein-C Peptide Analog: In Vitro Studies of Surface Physical Properties
Yonsei Medical Journal
2016 .01
-
A Combination of Short and Simple Surfactant Protein B and C Analogues as a New Synthetic Surfactant: In Vitro and Animal Experiments
Yonsei Medical Journal
2017 .07
-
Effect of surfactant on the preparation and characterization of gemcitabine-loaded particles
Journal of Pharmaceutical Investigation
2019 .01
-
Toxicity evaluation of surfactants using daphnia magna
한국실험동물학회 학술발표대회 논문집
2022 .01
-
Comparison of Respiratory Outcome between the Surfactant without Endotracheal Tube Intubation and the Intubation-Surfactant-Extubation Techniques in Extremely Low Gestational Age Neonates with Respiratory Distress Syndrome
Perinatology
2021 .09
-
Mathematical modelling for pulmonary surfactant lowering surface tension
대한체질인류학회 학술대회 연제 초록
2022 .05
-
History of Pulmonary Surfactant Replacement Therapy for Neonatal Respiratory Distress Syndrome in Korea
Journal of Korean Medical Science
2019 .01
-
Comparison of Respiratory Outcomes between Less Invasive Surfactant Administration and the Intubation- Surfactant-Extubation Technique in Premature Infants with Respiratory Distress Syndrome
Neonatal medicine
2020 .01
-
Lung Ultrasonography for the Diagnosis of Respiratory Distress Syndrome in Late Preterm Infants: Changing Incidence – A Single Center Experience
Neonatal medicine
2017 .01
-
최소 침습 폐표면활성제 투여법
Perinatology
2015 .01
-
Is Less Invasive Surfactant Administration Better than INtubation-SURfactant-Extubation for Prophylactic Surfactant Replacement Therapy?
Neonatal medicine
2022 .02
-
Transient intubation for surfactant administration in the treatment of respiratory distress syndrome in extremely premature infants
Clinical and Experimental Pediatrics
2018 .01
-
Application of factorial design approach in development and evaluation of self microemulsifying drug delivery system (SMEDDS) of mebendazole
Journal of Pharmaceutical Investigation
2017 .11
-
Transcription Factor PU.1 Inhibits Aspergillus fumigatus Infection via Surfactant Protein-D
대한의생명과학회지
2018 .09
-
분체와 유화제의 상호 관계성에 기인한 저점도 W/O 및 W/S 에멀젼의 안정성 연구
대한화장품학회지
2016 .01
-
Early Prophylactic Use of Curosurf® Versus Newfactan® for Respiratory Distress Syndrome in Premature Infants
Perinatology
2016 .01
-
Response surface optimization of self nano-emulsifying drug delivery system of rosuvastatin calcium for hepatocellular carcinoma
Journal of Pharmaceutical Investigation
2021 .01
이 논문의 저자 정보
최근 본 자료
댓글(0)
0